These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 38713397

  • 21. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ.
    Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
    [Abstract] [Full Text] [Related]

  • 22. Multilayered pigment epithelial detachment in neovascular age-related macular degeneration.
    Rahimy E, Freund KB, Larsen M, Spaide RF, Costa RA, Hoang Q, Christakopoulos C, Munch IC, Sarraf D.
    Retina; 2014 Jul; 34(7):1289-95. PubMed ID: 24675391
    [Abstract] [Full Text] [Related]

  • 23. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
    Zhao XY, Xia S, Luo MY, Wang EQ, Chen YX.
    Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lam D, Semoun O, Blanco-Garavito R, Jung C, Nguyen DT, Souied EH, Mimoun G.
    Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
    [Abstract] [Full Text] [Related]

  • 26. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB.
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [Abstract] [Full Text] [Related]

  • 27. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.
    Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060
    [Abstract] [Full Text] [Related]

  • 28. [Anti-VEGF-therapy of fibrovascular and serous-vascularized pigment epithelial detachment in neovascular AMD : A retrospective five-year-analysis].
    Barth T, Reiners M, Zeman F, Greslechner R, Helbig H, Gamulescu MA.
    Ophthalmologe; 2021 Dec; 118(12):1255-1263. PubMed ID: 33320292
    [Abstract] [Full Text] [Related]

  • 29. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
    Giansanti F, Bacherini D, Giacomelli G, Virgili G, Finocchio L, Fiore T, Vannozzi L, Menchini U.
    Eur J Ophthalmol; 2014 Dec; 24(3):402-8. PubMed ID: 24242217
    [Abstract] [Full Text] [Related]

  • 30. Volumetric Analysis of Vascularized Serous Pigment Epithelial Detachment Progression in Neovascular Age-Related Macular Degeneration Using Optical Coherence Tomography Angiography.
    Au A, Hou K, Dávila JP, Gunnemann F, Fragiotta S, Arya M, Sacconi R, Pauleikhoff D, Querques G, Waheed N, Freund KB, Sadda S, Sarraf D.
    Invest Ophthalmol Vis Sci; 2019 Aug 01; 60(10):3310-3319. PubMed ID: 31369033
    [Abstract] [Full Text] [Related]

  • 31. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S, Polat O, Karadas M, Inan UU.
    Rom J Ophthalmol; 2019 Aug 01; 63(3):238-244. PubMed ID: 31687625
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.
    Chan CK, Abraham P, Sarraf D, Nuthi AS, Lin SG, McCannel CA.
    Eye (Lond); 2015 Jan 01; 29(1):80-7. PubMed ID: 25277305
    [Abstract] [Full Text] [Related]

  • 39. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 01; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 40. QUANTITATIVE ANALYSIS OF PIGMENT EPITHELIAL DETACHMENT RESPONSE TO DIFFERENT ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS IN WET AGE-RELATED MACULAR DEGENERATION.
    Balaskas K, Karampelas M, Horani M, Hotu O, Keane P, Aslam T.
    Retina; 2017 Jul 01; 37(7):1297-1304. PubMed ID: 27755376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.